Heparanase mRNA expression and point mutation in hepatocellular carcinoma

Figure 1 Expression of HPA mRNA in HCC. M: molecular mass markers (DL2000); lanes 1 and 3: the noncancerous liver tissue; lanes 2 and 4: the HPA positive samples of cancer tissues both with a bright band at 585 bp.

Figure 2 Electrophoretogram of the recombinant plasmid DNA digested by EcoRI. M: molecular mass markers (DL2000); lanes 1 and 2: the pure HPA RT-PCR products; lanes 3 and 4: the products of digestion; lanes 5 and 6: the products without digestion.

Figure 3 The sequencing map 1 (A) and map 2 (B) ↑, the mu-tated base; the parts with underline, the codons.